Amneal Pharmaceuticals Q3 Adj. EPS $0.04 Misses $0.14 Estimate, Sales $378M Miss $410.98M Estimate

Amneal Pharmaceuticals (NYSE:AMRX) reported quarterly earnings of $0.04 per share which missed the analyst consensus estimate of $0.14 by 71.43 percent. This is a 85.71 percent decrease over earnings of $0.28 per share

Benzinga · 11/06/2019 11:36

Amneal Pharmaceuticals (NYSE:AMRX) reported quarterly earnings of $0.04 per share which missed the analyst consensus estimate of $0.14 by 71.43 percent. This is a 85.71 percent decrease over earnings of $0.28 per share from the same period last year. The company reported quarterly sales of $378 million which missed the analyst consensus estimate of $410.98 million by 8.02 percent. This is a 20.67 percent decrease over sales of $476.487 million the same period last year.